Does the Microflora of Surgery Site Infection Change After Prophylactic Use of Vancomycin Powder in the Spine Surgery

References

• Horii C, Yamazaki T, Oka H, et al. Does intrawound vancomycin powder reduce surgical site infection after posterior instrumented spinal surgery? A propensity score-matched analysis. Spine J. 2018;18(12):2205–2212. doi:10.1016/j.spinee.2018.04.015
   PubMed Web of Science ®Google Scholar
• Hovis JP, Montalvo R, Marinos D, et al. Intraoperative vancomycin powder reduces Staphylococcus aureus surgical site infections and biofilm formation on fixation implants in a rabbit model. J Orthop Trauma. 2018;32(5):263–268. doi:10.1097/BOT.0000000000001136
   PubMed Web of Science ®Google Scholar
• Park HY, Hegde V, Zoller SD, et al. Progress not panacea: vancomycin powder efficacy and dose evaluated in an in vivo mouse model of spine implant infection. Spine J. 2020;20(6):973–980. doi:10.1016/j.spinee.2019.12.007
   PubMed Web of Science ®Google Scholar
• Dodson V, Majmundar N, Swantic V, Assina R. The effect of prophylactic vancomycin powder on infections following spinal surgeries: a systematic review. Neurosurg Focus. 2019;46(1):E11. doi:10.3171/2018.10.FOCUS18470
   PubMed Web of Science ®Google Scholar
• Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine. 2011;36(24):2084–2088. doi:10.1097/BRS.0b013e3181ff2cb1
   PubMed Web of Science ®Google Scholar
• Van Hal M, Lee J, Laudermilch D, Nwasike C, Kang J. Vancomycin powder regimen for prevention of surgical site infection in complex spine surgeries. Clin Spine Surg. 2017;30(8):E1062–E1065. doi:10.1097/BSD.0000000000000516
   PubMed Web of Science ®Google Scholar
• Adogwa O, Elsamadicy AA, Sergesketter A, et al. Prophylactic use of intraoperative vancomycin powder and postoperative infection: an analysis of microbiological patterns in 1200 consecutive surgical cases. J Neurosurg Spine. 2017;27(3):328–334. doi:10.3171/2017.2.SPINE161310
   PubMed Web of Science ®Google Scholar
• Guzek A, Rybicki Z, Tomaszewski D. Changes in bacterial flora and antibiotic resistance in clinical samples isolated from patients hospitalized in the Military Institute of Medicine in Warsaw, Poland, between 2005–2012. Przegl Epidemiol. 2017;71(2):165–176.
   PubMedGoogle Scholar
• Esposito S, Capuano A, Noviello S, et al. Modification of patients’ endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother. 2003;15(6):568–573. doi:10.1179/joc.2003.15.6.568
   PubMed Web of Science ®Google Scholar
• Sudduth JD, Moss JA, Spitler CA, et al. Open fractures: are we still treating the same types of infections? Surg Infect. 2020;21(9):766–772. doi:10.1089/sur.2019.140
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski J, Blanchard JC, et al. Introduction to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Guideline for the prevention of surgical site infections. Surg Infect. 2017;18(4):385–393. doi:10.1089/sur.2017.075
   PubMed Web of Science ®Google Scholar
• Russo V, Leaptrot D, Otis M, Smith H, Hebden JN, Wright MO. Health care-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network Data Quality Collaboration Case Study - chapter 9 surgical site infection event (SSI) case study. Am J Infect Control. 2022;50(7):799–800. doi:10.1016/j.ajic.2022.03.036
   PubMed Web of Science ®Google Scholar
• Khan NR, Thompson CJ, DeCuypere M, et al. A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine. 2014;21(6):974–983. doi:10.3171/2014.8.SPINE1445
   PubMed Web of Science ®Google Scholar
• Garg S, Bloch N, Potter M, et al. Topical vancomycin in pediatric spine surgery does not reduce surgical site infection: a retrospective cohort study. Spine Deform. 2018;6(5):523–528. doi:10.1016/j.jspd.2018.01.010
   PubMedGoogle Scholar
• Fernandes MM, Ivanova K, Hoyo J, Pérez-Rafael S, Francesko A, Tzanov T. Nanotransformation of vancomycin overcomes the intrinsic resistance of gram-negative bacteria. ACS Appl Mater Interfaces. 2017;9(17):15022–15030. doi:10.1021/acsami.7b00217
   PubMed Web of Science ®Google Scholar
• Turner RD, Hurd AF, Cadby A, Hobbs JK, Foster SJ. Cell wall elongation mode in Gram-negative bacteria is determined by peptidoglycan architecture. Nat Commun. 2013;4:1496. doi:10.1038/ncomms2503
   PubMed Web of Science ®Google Scholar
• Yarlagadda V, Manjunath GB, Sarkar P, et al. Glycopeptide antibiotic to overcome the intrinsic resistance of gram-negative bacteria. ACS Infect Dis. 2016;2(2):132–139. doi:10.1021/acsinfecdis.5b00114
   PubMed Web of Science ®Google Scholar
• Ghobrial GM, Thakkar V, Andrews E, et al. Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine. 2014;39(7):550–555. doi:10.1097/BRS.0000000000000241
   PubMed Web of Science ®Google Scholar
• Rosa CP, Pereira JA, Cristina de Melo Santos N, et al. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model. J Leukoc Biol. 2020;107(1):95–104. doi:10.1002/JLB.4AB0919-432R
   PubMed Web of Science ®Google Scholar
• Scheithauer TPM, Bakker GJ, Winkelmeijer M, et al. Compensatory intestinal immunoglobulin response after vancomycin treatment in humans. Gut Microbes. 2021;13(1):1–14. doi:10.1080/19490976.2021.1875109
   PubMed Web of Science ®Google Scholar
• Karaman R, Jubeh B, Breijyeh Z. Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches. Molecules. 2020;25(12):2888. doi:10.3390/molecules25122888
   PubMed Web of Science ®Google Scholar
• Kaye KS, Devine ST, Ford KD, Anderson DJ. Surgical site infection prophylaxis strategies for cardiothoracic surgery: a decision-analytic model. Scand J Infect Dis. 2012;44(12):948–955. doi:10.3109/00365548.2012.700118
   PubMed Web of Science ®Google Scholar
• Yue J, Dong BR, Yang M, Chen X, Wu T, Liu GJ. Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database Syst Rev. 2016;(1):CD008056. doi:10.1002/14651858.CD008056.pub3
   PubMed Web of Science ®Google Scholar
• Li J, Zhao QH, Huang KC, et al. Linezolid vs. vancomycin in treatment of methicillin-resistant staphylococcus aureus infections: a meta-analysis. Eur Rev Med Pharmacol Sci. 2017;21(17):3974–3979.
   PubMed Web of Science ®Google Scholar
• Equils O, da Costa C, Wible M, Lipsky BA. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin. BMC Infect Dis. 2016;16(1):476. doi:10.1186/s12879-016-1779-5
   PubMedGoogle Scholar
• Salimi S, Khayat Kashani HR, Azhari S, et al. Local vancomycin therapy to reduce surgical site infection in adult spine surgery: a randomized prospective study. Eur Spine J. 2022;31(2):454–460. doi:10.1007/s00586-021-07050-5
   PubMed Web of Science ®Google Scholar
• Dybowski BA, Zapała P, Bres-Niewada E, et al. Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern. BMC Infect Dis. 2018;18(1):590. doi:10.1186/s12879-018-3507-9
   PubMedGoogle Scholar
• Shetty HS, Mallela AR, Shastry BA, Acharya V. Parietal bone osteomyelitis in melioidosis. BMJ Case Rep. 2015;2015:bcr2014208612. doi:10.1136/bcr-2014-208612
   PubMedGoogle Scholar
• Gande A, Rosinski A, Cunningham T, Bhatia N, Lee YP. Selection pressures of vancomycin powder use in spine surgery: a meta-analysis. Spine J. 2019;19(6):1076–1084. doi:10.1016/j.spinee.2019.01.002
   PubMed Web of Science ®Google Scholar
• Aleissa S, Parsons D, Grant J, Harder J, Howard J. Deep wound infection following pediatric scoliosis surgery: incidence and analysis of risk factors. Can J Surg. 2011;54(4):263–269. doi:10.1503/cjs.008210
   PubMed Web of Science ®Google Scholar
• Cahill PJ, Warnick DE, Lee MJ, et al. Infection after spinal fusion for pediatric spinal deformity: thirty years of experience at a single institution. Spine. 2010;35(12):1211–1217. doi:10.1097/BRS.0b013e3181c212d1
   PubMed Web of Science ®Google Scholar
• Warner SJ, Uppstrom TJ, Miller AO, et al. Epidemiology of deep surgical site infections after pediatric spinal fusion surgery. Spine. 2017;42(3):E163–E168. doi:10.1097/BRS.0000000000001735
   PubMed Web of Science ®Google Scholar
• Maesani M, Doit C, Lorrot M, et al. Surgical site infections in pediatric spine surgery: comparative microbiology of patients with idiopathic and nonidiopathic etiologies of spine deformity. Pediatr Infect Dis J. 2016;35(1):66–70. doi:10.1097/INF.0000000000000925
   PubMed Web of Science ®Google Scholar
• Glotzbecker M, Troy M, Miller P, et al. Implementing a multidisciplinary clinical pathway can reduce the deep surgical site infection rate after posterior spinal fusion in high-risk patients. Spine Deform. 2019;7(1):33–39. doi:10.1016/j.jspd.2018.06.010
   PubMedGoogle Scholar
• Vandenberg C, Niswander C, Carry P, et al. Compliance with a comprehensive antibiotic protocol improves infection incidence in pediatric spine surgery. J Pediatr Orthop. 2018;38(5):287–292. doi:10.1097/BPO.0000000000000812
   PubMed Web of Science ®Google Scholar